COMMUNIQUÉS West-GlobeNewswire
-
The Coalition for Physician & APP Well-Being Launches “The Initiative Intelligence Guide” to Help Health Systems Better Evaluate Workforce, Retention, and Operational Initiatives
15/07/2026 -
Attovia Therapeutics Appoints John W. Smither to Board of Directors
15/07/2026 -
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
15/07/2026 -
iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery
15/07/2026 -
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
15/07/2026 -
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
15/07/2026 -
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
15/07/2026 -
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
15/07/2026 -
NOMAD Power Solutions Strengthens Subsidiary Executive Leadership
15/07/2026 -
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026 -
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
15/07/2026 -
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
15/07/2026 -
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
15/07/2026 -
Mixie Technologies, Inc. (OTC: MIXE) Completes Corporate Rebranding and Trading Symbol Change
15/07/2026 -
Biogen Appoints Michael J. Parini as Chief Legal Officer
15/07/2026 -
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
15/07/2026 -
Sienna Announces July Dividend
15/07/2026 -
Cannara annonce un chiffre d’affaires record au troisième trimestre et une rentabilité soutenue, parallèlement à l’extension de sa distribution nationale et à l’accélération de l’augmentation de ses capacités
15/07/2026 -
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
15/07/2026
Pages